TELA Projected Dividend Yield
TELA Bio Inc ( NASDAQ : TELA )TELA Bio, Inc. is a commercial-stage medical technology company. Co. is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. Co.'s OviTex products include OviTex 1S, OviTex 2S, and OviTex LPR. 21 YEAR PERFORMANCE RESULTS |
TELA Dividend History Detail TELA Dividend News TELA Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |